GConferenceGridThe Conference Catalogue · Vol. 2026Folio № 357E3D
Of the Field

Next Generation Dx Summit 2026

N

ext Generation Dx Summit 2026 is the premier event for decision-makers in advanced diagnostics, bringing together over 400 diagnostics professionals and more than 120 innovation-leading speakers. The event covers a wide scope across clinical and molecular diagnostics, featuring six focused tracks on breakthrough technologies, commercial strategy, and regula…

Visit the official site
11Voices
0Underwriters
0Exhibitors
0On the bill · sessions
11Companies · in total
§I

The Voices

Programmed at Next, in alphabetical order.
Brian P. Carey, JD
Partner · Hogan Lovells US LLP
Christine C. Ginocchio, PhD
MT(ASCP), CMO · Qiagen
Courtney H. Lias, PhD
Director, OHT7: Office of in vitro Diagnostic Devices, United States Food and Drug Administration (FDA) · FDA
Elissa Quinn
Medical Director, Cancer Screening & Early Detection · AstraZeneca
Ipsita G. Smolinski, MBA
Managing Director, Capitol Street; Faculty, Georgetown University · Capitol Street / Georgetown University
Jai Pandey, PhD
Head, Global Device Regulatory IVD/CDx and Digital Health · Sanofi
Phillips Kuhl
Founder & Chairman · Cambridge Healthtech Institute
Sheila D. Walcoff, JD
Founding Principal & CEO · Goldbug Strategies LLC
Susan Van Meter
President · American Clinical Laboratory Association
Taylor Jensen, PhD
Vice President, Head of Science, Oncology · Labcorp
Zach Rothstein, JD
Executive Director · AdvaMedDx
Intermission
Part the Second · For the Buyer

An audience of 11 companies, parsed from the program.

“Eleven companies in attendance.”

The numbers below are derived from the speakers, sponsors, and exhibitors on this page — cross-referenced into one ledger. They are the only thing here that 10times.com cannot tell you.

№ 01Fig. 01 — Composition of the House
0All threespeak · spons · exh
0Sponsoringsponsor only
0Exhibitingexhibitor only
11Speakingspeaker only
№ 02Fig. 02 — The Voices, by Seniority

82% of the speakers carry senior titles — C-suite, Founder, VP, or Director-level.

  • C-suite218%
  • Founder / Owner218%
  • VP-level19%
  • Director / Head of436%
  • Other roles218%

Of 11 on the bill · classified by free-text title

№ 03Fig. 03 — The Heaviest in the Room
  1. 01AdvaMedDx1V
  2. 02American Clinical Laboratory Association1V
  3. 03AstraZeneca1V
  4. 04Cambridge Healthtech Institute1V
  5. 05Capitol Street / Georgetown University1V
  6. 06FDA1V
  7. 07Goldbug Strategies LLC1V
  8. 08Hogan Lovells US LLP1V
  9. 09Labcorp1V
  10. 10Qiagen1V
  11. 11Sanofi1V
№ 04Fig. 04 — By Tier

Tiers were not disclosed for this convocation.